Evidence from neuropathological examinations and transgenic models underscores the pivotal role of NLRP3 in AD progression, facilitating the accumulation of β-amyloid and tau pathology (Pereira et al., 2019). The gene discussed is MAPT; the disease is Alzheimer disease.